Mylan Bids To Win EU Approval For Upjohn Merger
New Zealand Watchdog Also Raises Potential Concerns
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.